Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Total Current Liabilities (2016 - 2025)

Nephros (NEPH) has 16 years of Total Current Liabilities data on record, last reported at $2.5 million in Q3 2025.

  • For Q3 2025, Total Current Liabilities rose 133.18% year-over-year to $2.5 million; the TTM value through Sep 2025 reached $2.5 million, up 133.18%, while the annual FY2024 figure was $1.6 million, 26.08% down from the prior year.
  • Total Current Liabilities reached $2.5 million in Q3 2025 per NEPH's latest filing, up from $1.8 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $2.5 million in Q3 2025 and bottomed at $1.1 million in Q3 2024.
  • Average Total Current Liabilities over 5 years is $1.8 million, with a median of $1.8 million recorded in 2025.
  • Peak YoY movement for Total Current Liabilities: plummeted 54.7% in 2021, then surged 133.18% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $2.4 million in 2021, then tumbled by 40.92% to $1.4 million in 2022, then skyrocketed by 49.65% to $2.1 million in 2023, then decreased by 26.08% to $1.6 million in 2024, then surged by 57.94% to $2.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $2.5 million in Q3 2025, $1.8 million in Q2 2025, and $1.5 million in Q1 2025.